sábado, 5 de agosto de 2017

Antibiotic Resistance Lab Network | Antibiotic/Antimicrobial Resistance | CDC

Antibiotic Resistance Lab Network | Antibiotic/Antimicrobial Resistance | CDC

Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People

CDC Invests in States to Combat Existing and Emerging Antibiotic Resistance

AR Lab Network logo

This week, CDC provided $77 million to help state and local health departments fight local AR threats affecting foodborne infections and infections in healthcare facilities and communities. As part of this investment, CDC’s Antibiotic Resistance Laboratory Network (AR Lab Network) will be better able to sound the alarm when known and emerging AR threats are detected. Data generated by the AR Lab Network can help improve infection control in healthcare facilities and inform more rapid and effective responses to outbreaks.
The 2017 funding enhances the AR Lab Network activities by:
  • Increasing testing nationwide for the fungal threat Candida, including emerging drug-resistant Candida auris fungi.
  • Strengthening national tuberculosis (TB) surveillance and infrastructure by adding a new national laboratory, called the National TB Molecular Surveillance Center. 
  • Enhancing detection of drug-resistant gonorrhea threats using whole genome sequencing (WGS).
The $77 million will also be used to build on the successes of PulseNet, the national laboratory network that connects foodborne illness cases to detect outbreaks. Every state public health lab will work toward performing WGS on food and waterborne bacteria, including SalmonellaShigella, and Campylobacter. All 50 states, six large cities and Puerto Rico will also continue to test for carbapenem-resistant Enterobacteriaceae (CRE)—the deadly germ resistant to nearly all antibiotics.
The awards support activities related to CDC’s Antibiotic Resistance Solutions Initiative and implementation of the surveillance, prevention, and stewardship activities outlined in the national goals to combat antibiotic resistance.
CDC made these critical investments to state, territorial and local public health programs through CDC’s Epidemiology and Laboratory Capacity (ELC) for Infectious Diseases Cooperative Agreement. Overall, CDC awarded more than $200 million this week to help states respond to infectious disease threats.
Take Action 
  • Read CDC’s press release to learn how these enhancements will help combat AR.
  • Learn more about CDC’s AR Lab Network and use the two new factsheets.
  • Read a story highlighting how the AR Lab Network helped CDC respond to the emerging resistant fungus C. auris.

No hay comentarios:

Publicar un comentario